Correspondence Infant mortality (per thousand livebirths)
group on HIV in women and children. Mortality among infected and uninfected
Africa: a pooled analysis. Lancet 2004; 364:
Abrams EJ, Wiener J, Carter R, et al. Maternal
health factors and early pediatric antiretroviral
therapy inﬂuence the rate of perinatal HIV-Idisease progression in children. AIDS, 2003;
Table: Infant mortality rates in countries included in article by Newell and 17: 867–77. colleagues
Combination antiretroviral strategies for thetreatment of pregnant HIV-I-infected women
and prevention of perinatal HIV-I transmission.
We thank Mary Pat Kieffer for empha- Table (above) created by the
J Acquir Immune Deﬁc Syndr 2002; 29: 484–94.
Jourdain G, Ngo-Giang-Huong N, Le Coeur S,
et al. Intrapartum exposure to nevirapine and
support and treatment for all HIV- compiler/start.cfm?action=new_
subsequent maternal responses to nevirapine-
infected mothers and vertically HIV- table&userid=128376&usertabid
based antiretroviral therapy. N Engl J Med 2004;
infected children who are eligible on the
5Morris L, Martinson N, Pillay C, et al. McIntyre
basis of clinical or immunological dis- 2004)
persistence of nevirapine resistance mutations
6 months following single dose nevirapine. XV
Thailand, July 2004: abstract ThOrB1353.
not seem to have taken this ﬁnding into
they are likely to be ill less frequently,
effect on mortality rate, then surely the
ated with lower infant mortality via pro-
this population, as it does in others. This
study died at age younger than 1 year.
return for their results, and overall less
within the ﬁrst few months of life.
I declare that I have no conﬂict of interest
I declare that I have no conﬂict of interest. The
opinions expressed here are those of the author and
4701 Willard Avenue, Apartment 907, Chevy Chase,
Rollins N, Gaillard P, Dabis F for the Ghent
International AIDS Society (IAS) working group
on HIV in women and children. Mortality among
USAID/REDSO-ESA, PO Box 30261, Nairobi, Kenya
infected and uninfected infants born to HIV-
infected mothers in Africa: a pooled analysis.
Rollins N, Gaillard P, Dabis F for the Ghent
Lancet 2004; 364: 1236–43.
globally,2 and initiatives from the United
www.thelancet.com Vol 365 January 8, 2005 Correspondence A prion lexicon (out of control)
Ted Greiner refers to the ﬁnding that in
tions there was no signiﬁcant difference
for either infected or uninfected children.
and r PrP’s. In fact, it has already been
likely to be found in the limited statistical
group that 20 years ago gave us its orig-
Molecular model of conversion of normal to misfolded protein
Coils are ␣ helices, ribbons are pretation that our ﬁndings suggest that
␤ sheets. breastfed children have lower mortality protein, only the abnormal protein, or and comprehension, but if abbrevia-
the present day. Also, the pairing of PrPc
cellular protein, and PrPTSE for any of its
ground mortality is lower than in east or
use, but it is manifestly inappropriate to
signiﬁcant effect of feeding modality on
tors may also explain some of the differ-
PrPCJD, PrPGSS, PrPFFI, PrPBSE, PrPCWD, and
We declare that we have no conﬂict of interest. email@example.com
We declare that we have no conﬂict of interest.
were the most accurate representationsof prion terminology (although PrPsen is
*7815 Exeter Road, Bethesda, MA 20814, USA (PB);and Jerome H Holland Laboratory, American Red
*Marie-Louise Newell, Hoosen Coovadia,
a contradiction in terms if PrP is under-
Mario Cortina-Borja, Nigel Rollins,
Caughey B, Neary K, Duller R, et al. Normal
neuroblastoma cells. J Virol 1990; 64: firstname.lastname@example.org
Centre for Paediatric Epidemiology, Institute of Child
Politopolou G. Experimental approaches to TSE
prevention via inhibition of prion formation.
ate),2 and the fraternal twins, sPrPSc and
Prot Peptide Lett 2004; 11: 249–55.
Gaillard P, Fowler MG, Dabis F, et al. Use ofantiretroviral drugs to prevent HIV-1
Tremblay P, Ball HL, Kaneko K, et al. Mutant PrPSc conformers induced by a
transmission through breastfeeding: from
synthetic peptide and several prion strains.
animal studies to randomized clinical trials. J Acquir Immune Deﬁc Syndr 2004; 35: J Virol 2004; 78: 2088–99.
Jeffrey M, Martin S, Gonzalez L. Cell-associated variants of disease-speciﬁc prion
WHO. Scaling up antiretroviral therapy in
resource-limited settings: treatment guidelinesfor a public health approach. Geneva: World
different sources of sheep transmissiblespongiform encephalopathy. J Gen Virol
2003; 84: 1033–45.
5Serban A, Legname G, Hansen K, Kovaleva N,
associated with reasons for non-breastfeedingand weaning: is breastfeeding best for HIV-
Prusiner SB. Immunoglobulins in urine ofhamsters with scrapie. J Biol Chem 2004;
positive mothers? AIDS 2003; 17: 879–85.
has recently appeared in print—PrPd (for
www.thelancet.com Vol 365 January 8, 2005
The SAR Newsletter is published by Society for Acupuncture Research (http://www.acupunctureresearch.org/) Welcome to SAR's Summer 2011 newsletter. This issue provides you with selected information on recent and upcoming meetings and events, acupuncture in the news, highlights of new relevant research, and more. SAR Newsletter Committee SAR's newsletter will keep you up-to-date a
INSTRUCTIVO PARA LA VINCULACIÓN CON TERCEROS 1.- OBJETO El presente instructivo brinda información clara y sencil a para la vinculación de la UNLP conterceros, con la finalidad de cumplimentar los requisitos legales que regulan la materia a losefectos de salvaguardar las responsabilidades que, en materia civil, económica y/o penal, sepueden derivar de los compromisos asumidos. Asimismo,